Rosemont Pharmaceuticals
Richard Mansfield is an experienced professional in the pharmaceutical and healthcare industries, currently serving as a Product Specialist and Territory Manager at Syneos and Idorsia since June 2024, focusing on chronic insomnia. In addition to this role, Richard has been a Territory Business Manager at Rosemont Pharmaceuticals since May 2023, following a similar position at Eli Lilly and Company from June 2020 to May 2023. Previous roles include Aesthetic Business Manager at Alliance Pharmaceuticals Limited and Account Manager positions at HA-DERMA LIMITED and Johnson & Johnson. Richard's career began as a Business Development Executive at Galderma, where responsibilities included increasing market share in dermatology, and prior to that, worked as a Dermatology Specialist at IQVIA. Initial experience entails roles in sales and education, including positions at Nova Group Japan and CustomCall. Richard holds a degree in Media Studies and I.T, with a focus on Advertising and Marketing from Sheffield Hallam University.
Rosemont Pharmaceuticals
At Rosemont our mission is to be a rapid developer, reliable manufacturer and global supplier of novel-delivery, patient-focused medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them. We are highly respected in the industry and have been instrumental in establishing best practice for the care of patients with swallowing difficulties. Rosemont advocate the use of liquid medication over manipulating solid dose medications and we have a range of educational materials designed for healthcare professionals which focuses on key patient groups and their medication management challenges. At Rosemont we have a portfolio of over 130 oral liquid medicines across a range of therapeutic areas including 70 licensed products. All of our products, both licensed and ‘specials’ are made to the same exacting standards under GMP. Our UK range also includes 9 products licensed for use with PEG/NG tubes. We are always seeking to expand our range of medicines and covert our ‘specials’ to licensed product wherever possible.